Ignite Creation Date:
2025-12-24 @ 5:16 PM
Ignite Modification Date:
2025-12-24 @ 5:16 PM
Study NCT ID:
NCT04143750
Status:
COMPLETED
Last Update Posted:
2020-04-03
First Post:
2019-10-21
Is Possible Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
The Mass Balance and Biotransformation of [14C] Vicagrel in Healthy Man
Sponsor:
Jiangsu vcare pharmaceutical technology co., LTD
Organization:
Study Overview
Official Title:
The Mass Balance and Biotransformation Study of [14C] Vicagrel in Chinese Healthy Adult Male Volunteers
Status:
COMPLETED
Status Verified Date:
2020-04
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
None
Brief Summary:
This study was designed to evaluate the mass balance and biotransformation after single-dose of \[14C\]Vicagrel orally in Chinese healthy male volunteers, revealing the overall pharmacokinetic characteristics of vicagrel in humans, and providing a reference for the rational administration.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
False
Is a FDA Regulated Device?:
False
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: